Eosinophilic annular erythema treated with dupilumab
- PMID: 29790187
- DOI: 10.1111/pde.13533
Eosinophilic annular erythema treated with dupilumab
Abstract
Eosinophilic annular erythema is a rare, benign, recurrent condition characterized by annular skin lesions, tissue eosinophilia, and resistance to a variety of treatments. There are fewer than 30 cases reported in the English literature, 7 of which are in children. We present a case of recurrent eosinophilic annular erythema in an adolescent that was successfully treated with dupilumab, an interleukin-4 receptor alpha antagonist.
Keywords: pharmacology; therapy-systemic; urticaria.
© 2018 Wiley Periodicals, Inc.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        